Substance / Medication

Iron dextran

Overview

Active Ingredient
iron-dextran complex
RxNorm CUI
5992

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy and safety of total dose infusion of low molecular weight iron dextran in the treatment of iron deficiency anemia during pregnancy.
Ayub Rukhsana, Tariq Nabia, Adil Malik Muhammad et al. · J Coll Physicians Surg Pak · 2008
PMID: 18760066RCT
Comparison of adverse-event profiles of intravenous low-molecular-weight iron dextran and iron sucrose in peritoneal dialysis patients.
Solak Yalcin, Atalay Huseyin, Guney Ibrahim et al. · Ren Fail · 2011
PMID: 21401355Observational
[Treatment of iron deficiency by a bolus intravenous iron dextran in peritoneal dialysis].
Ficheux Maxence, Cuny Pascale, Lecouf Angélique et al. · Nephrol Ther · 2011
PMID: 21715234Observational
Safety profiles of total dose infusion of low-molecular-weight iron dextran and high-dose iron sucrose in renal patients.
Atalay Huseyin, Solak Yalcin, Acar Kadir et al. · Hemodial Int · 2011
PMID: 21564503Observational
Efficacy and tolerability of intravenous iron dextran and oral iron in inflammatory bowel disease: a case-matched study in clinical practice.
Khalil Asma, Goodhand James R, Wahed Mahmood et al. · Eur J Gastroenterol Hepatol · 2011
PMID: 21857526Observational
Low-molecular-weight iron dextran in the management of renal anaemia in patients on haemodialysis--the IDIRA Study.
Rath Thomas, Florschütz Kai, Kalb Klaus et al. · Nephron Clin Pract · 2010
PMID: 19887827Observational
Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.
Sinha Smeeta, Chiu Diana Y Y, Peebles George et al. · J Ren Care · 2009
PMID: 19432851Observational
Use of iron sucrose in dialysis patients sensitive to iron dextran.
Haddad Ayham, Abbadi Rabe'a, Marji Ann · Saudi J Kidney Dis Transpl · 2009
PMID: 19237805Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Iron dextran (substance)
SNOMED CT
387118003
UMLS CUI
C0022092
RxNorm CUI
5992

Clinical Data

This intervention maps to 8 entities in the Ltrl knowledge graph.

1
Conditions
3
Biomarkers
2
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.